NCT00080795
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
Clinical trial condition
Urethral Neoplasms
Explore clinical trials studying Urethral Neoplasms. Study availability and eligibility vary by location and protocol.
82 public trials
7 recruiting studies
Urethral Neoplasms trial results
NCT00014144
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- CCOP - Greater Phoenix Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
NCT00006026
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- U.Z. Gasthuisberg Leuven, Belgium
- Centre Jean Perrin Clermont-Ferrand, France
- Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France
- CRLCC Nantes - Atlantique Nantes-Saint Herblain, France
NCT00006351
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University Medical Center Nijmegen Nijmegen, Netherlands
NCT00020579
- Conditions
- AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
- Locations
-
- National Naval Medical Center Bethesda, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
NCT00661609
- Conditions
- Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +21 more
- Locations
-
- Research Site Palo Alto, California, United States
- Research Site San Bernardino, California, United States
- Research Site Southington, Connecticut, United States
- Research Site Miami, Florida, United States
NCT00049296
- Conditions
- AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00077688
- Conditions
- Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
Active, Not Recruiting
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
NCT05092958
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, +30 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Sutter Auburn Faith Hospital Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont Fremont, California, United States
Active, Not Recruiting
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
NCT03237780
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Urothelial Carcinoma, +36 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Keck Medicine of USC Buena Park Buena Park, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States